95 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 2

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HCAR3Hydroxycarboxylic acid receptor 3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Cell JunctionsTissue enhanced
HCRTR1Hypocretin (orexin) receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
HCRTR2Hypocretin (orexin) receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Not detected
HRH1Histamine receptor H1FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Cytosol
Mixed
HRH2Histamine receptor H2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
HRH3Histamine receptor H3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR1A5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupledDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
HTR1B5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Plasma membraneTissue enhanced
HTR1D5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
HTR1F5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
HTR2A5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR2B5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
NucleoplasmTissue enhanced
HTR2C5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR45-hydroxytryptamine (serotonin) receptor 4, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HTR65-hydroxytryptamine (serotonin) receptor 6, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Not detected
HTR75-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
RAS pathway related proteins
Nuclear speckles
Plasma membrane
Cytosol
Group enriched
LHCGRLuteinizing hormone/choriogonadotropin receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Group enriched
MC2RMelanocortin 2 receptor (adrenocorticotropic hormone)Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
MTNR1AMelatonin receptor 1AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
MTNR1BMelatonin receptor 1BFDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
NTSR2Neurotensin receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
OPRD1Opioid receptor, delta 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
OPRK1Opioid receptor, kappa 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
OPRM1Opioid receptor, mu 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
OXTROxytocin receptorFDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
P2RY12Purinergic receptor P2Y, G-protein coupled, 12Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
P2RY2Purinergic receptor P2Y, G-protein coupled, 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
CytosolTissue enhanced
PTGER1Prostaglandin E receptor 1 (subtype EP1), 42kDaFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
PTGER2Prostaglandin E receptor 2 (subtype EP2), 53kDaFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
PTGER3Prostaglandin E receptor 3 (subtype EP3)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
PTGER4Prostaglandin E receptor 4 (subtype EP4)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Expressed in all
PTGFRProstaglandin F receptor (FP)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
PTGIRProstaglandin I2 (prostacyclin) receptor (IP)FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PTH2RParathyroid hormone 2 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
S1PR5Sphingosine-1-phosphate receptor 5FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
SCTRSecretin receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
SMOSmoothened, frizzled class receptorCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Mixed
SPECC1L-ADORA2ASPECC1L-ADORA2A readthrough (NMD candidate)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
SSTR1Somatostatin receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
SSTR2Somatostatin receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
CytosolTissue enhanced
SSTR5Somatostatin receptor 5FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Plasma membraneTissue enhanced
TAAR1Trace amine associated receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
TACR1Tachykinin receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
TBXA2RThromboxane A2 receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Nuclear speckles
Plasma membrane
Mixed
TSHRThyroid stimulating hormone receptorCancer-related genes
Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched

« prev | Page of 2